ZTS
Zoetis Inc.
Zoetis Inc. is a global animal health company with a $56.8B market cap, showing a primary political signal of direct executive branch ownership by former President Donald J. Trump, who holds two equity positions and dividend income from the stock.
Govt Dependence
5/100
Regulatory Density
85/100
Lobbying Intensity
0/100
Political Signal
NEUTRAL
BusinessWhat ZTS does
Zoetis Inc. develops, manufactures, and commercializes medicines, vaccines, diagnostics, and other health products for livestock and companion animals. Its revenue is derived from sales across international markets, with a portfolio targeting major species. The company operates in the pharmaceutical sector, specifically animal health.
12 months past · 3 months futureZTS activity timeline
Congress
buy
sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened
+ added
− trimmed
closed
holds
Bills
past action (this ticker)
upcoming markup (sector)
★ carveout (this ticker)
240 trading days ·
30 congressional trades shown
·
0 insider buys
·
14 13F filings
·
1 past bill actions
·
3 upcoming markups
Executive Branch ConflictsZTS held by Trump-administration officials
1 cabinet/senior official reported ZTS positions in OGE Form 278 disclosures across 3 filings.
Lifetime Government AwardsZTS federal contracts by year
$9M
total awarded · 2019–2026
44
contracts on file
2019
peak year ($3M)
Top contracts by award amount
$2.8M
Department of Agriculture
2019-07-01
ZOETIS: DIVA CTR AG-6395-C-14-0110 OPTION YEAR 4 - CSF DIVA VACCINE
$1.3M
Department of Agriculture
2022-04-13
CLASSICAL SWINE FEVER VIRUS (CSFV) VACCINE, DIVA, SUITABLE FOR USE IN
$1000K
Department of Agriculture
2024-05-01
ZOETIS FLU DETECT AVIAN INFLUENZA VIRUS TYPE A ANTIGEN TEST KITS
$767K
Department of Agriculture
2024-04-02
DELIVERY ORDER FOR MYCOBACTERIUM BOVIS TUBERCULIN VIALS.
$671K
Department of Agriculture
2023-04-04
PURCHASE OF MYCOBACTERIUM BOVIS TUBERCULIN PPD
8 years · 44 contracts
Smart Money · 13F HoldingsHedge funds holding ZTS
$1.82B
Total ZTS held by tracked 13F funds
40
Funds with ZTS positions
+40
Funds opened this quarter
Citadel Advisors
$239M
opened
2024-03-31
D.E. Shaw & Co.
$234M
opened
2025-09-30
D.E. Shaw & Co.
$151M
opened
17 overlap
2025-12-31
Citadel Advisors
$145M
opened
17 overlap
2025-12-31
D.E. Shaw & Co.
$120M
opened
2025-06-30
Citadel Advisors
$119M
opened
2024-12-31
Citadel Advisors
$73M
opened
2025-06-30
Two Sigma Investments
$71M
opened
2024-03-31
32 more 13F positions tracked · quarterly delta charts available in member dashboard
Politicians Trading ZTSMembers of Congress with recent ZTS positions
9 politicians traded ZTS across 83 disclosed transactions totaling $1.1M (last 730 days).
Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just ZTS). 0-30 LOW · 30-60 MID · 60+ HIGH.
Ro Khanna
24 buys
17 sells
$353K
2026-01-29
LOW · 0
Jefferson Shreve
4 buys
4 sells
$260K
2025-05-12
LOW · 0
Markwayne Mullin
2 buys
3 sells
$248K
2025-11-10
LOW · 29
Lisa C. McClain
4 buys
4 sells
$64K
2025-08-04
LOW · 0
Gilbert Ray Cisneros
3 buys
4 sells
$56K
2026-04-14
HIGH · 61
Robert P. Bresnahan
2 buys
4 sells
$48K
2025-05-15
LOW · 0
Julie Johnson
4 sells
$32K
2025-04-01
LOW · 15
Rick Larsen
2 sells
$16K
2025-10-06
LOW · 2
Jared Moskowitz
2 sells
$16K
2024-07-05
LOW · 0
Congressional TradesWho in Congress is trading ZTS
2026-04-14
Gilbert Ray Cisneros
Sale
$1,001 - $15,000
2026-03-13
Gilbert Ray Cisneros
Sale
$1,001 - $15,000
2026-02-10
Gilbert Ray Cisneros
Purchase
$1,001 - $15,000
2026-01-29
Ro Khanna
Sale
$1,001 - $15,000
2026-01-13
Ro Khanna
Purchase
$1,001 - $15,000
2026-01-22
Ro Khanna
Sale
$15,001 - $50,000
2026-01-06
Ro Khanna
Purchase
$1,001 - $15,000
2026-01-22
Ro Khanna
Sale
$1,001 - $15,000
2025-12-19
Gilbert Ray Cisneros
Purchase
$1,001 - $15,000
2025-11-18
Gilbert Ray Cisneros
Purchase
$1,001 - $15,000
2025-11-10
Ro Khanna
Purchase
$1,001 - $15,000
2025-11-03
Ro Khanna
Purchase
$1,001 - $15,000
30+ trades on file · most recent 2026-05-08
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
Stock awards & option exercises
2
option exercises · $412K
For ZTS, executives receive stock primarily as compensation rather than via open-market purchases — typical for established large-cap firms.
Bills Affecting ZTSLive legislation impacting this stock
S.9 · 119th
Protection of Women and Girls in Sports Act of 2025
S.1387 · 119th
National Biotechnology Initiative Act of 2025
HR.2756 · 119th
National Biotechnology Initiative Act of 2025
S.1302 · 119th
Increasing Transparency in Generic Drug Applications Act
HR.1843 · 119th
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
HR.1492 · 119th
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates und
HR.1060 · 119th
Modern Authentication of Pharmaceuticals Act of 2025
HR.843 · 119th
Prompt Approval of Safe Generic Drugs Act
S.43 · 119th
Skinny Labels, Big Savings Act
S.63 · 119th
CBW Fentanyl Act
Political ProfileWhere ZTS sits in Washington
[object Object]
STRUCTURAL: High regulatory density (8 impacting bills) and federal contract presence ($9.26M across 7 agencies). EVIDENTIARY: Direct executive branch ownership (Trump holds 3 positions per `get_executive_branch_exposure.by_ticker[0].holdings`) and active congressional trading (2 members, 15 trades). Net: Evidentiary signals are mixed (executive ownership vs. congressional sales), offset by structural regulatory exposure.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Broad legislative exposure to multiple pharma-sector billsU.S. Congress"`Recent bill_impacts` lists 8 bills with non-zero impact_ratios, all in pharma sector."
Regulatory opportunities
-
Federal contracts across seven agencies, including USDA and HHSDepartment of Agriculture, Department of Health and Human Services"`get_government_precedent.federal_contracts_summary[0].agencies` lists 7 agencies with $9.26M in total obligations."
Capitol Hill AlliesChampions & critics
Congressional champions
Congressional critics
- No specific congressional critics identified.
Member intelligence layer
Live signals + predictions for ZTS — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades ZTS
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord
Frequently AskedAbout ZTS & political exposure
Does Zoetis Inc. (ZTS) hold federal contracts?
Yes. Zoetis Inc. has 44 federal contract awards totaling $9,259,674, primarily from agencies including Department of Agriculture, Department of Commerce, Department of Defense. See full contract list and amounts on this page.
Which Trump cabinet officials own ZTS stock?
1 Trump cabinet members or senior White House staff have disclosed holdings in ZTS on their OGE 278 financial disclosures, including Donald J. Trump. See the Cabinet Conflicts panel for details.
Has Congress traded ZTS stock?
390 congressional trades by 31 unique members of Congress, most recently on 2026-04-14. See the Congressional Trading panel for politician-by-politician breakdown.
What is ZTS political risk profile?
Government dependence: 5/100. Lobbying intensity: 0/100. Political signal: neutral. Donor party split: R 0% / D 0%.
How does GovGreed track ZTS political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. ZTS data is updated daily from these official federal sources.